SIRT3 Enhances Mesenchymal Stem Cell Longevity and DifferentiationRyan A. Denu|Oxidative Medicine and Cellular Longevity|2017Cited by 75
ATRX Loss Predicts Poor Outcomes and Reveals a Therapeutic Vulnerability to TEAD Inhibition in Soft Tissue SarcomasRyan A. Denu, Kunal Rai|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0